Gold nanocrystals have shown promise in reversing neurological deficits in patients with multiple sclerosis (MS) and Parkinson’s disease (PD).
Gold nanocrystals show promise to reverse neurological deficits in patients with multiple sclerosis (MS) and Parkinson’s disease (PD).
In the clinical trials, this nanomedicine exhibited the ability to solve energy-related disorders in patients’ brains.
These clinical studies were done by researchers from the UT Southwestern Medical Center, and the nanocrystals were administered to the patients regularly for 12 weeks.
Leave a reply